Cargando…
CRISPR-Cas9 Targeting of Hepatitis B Virus Covalently Closed Circular DNA Generates Transcriptionally Active Episomal Variants
Chronic hepatitis B virus (HBV) infection persists due to the lack of therapies that effectively target the HBV covalently closed circular DNA (cccDNA). We used HBV-specific guide RNAs (gRNAs) and CRISPR-Cas9 and determined the fate of cccDNA after gene editing. We set up a ribonucleoprotein (RNP) d...
Autores principales: | Martinez, Maria Guadalupe, Combe, Emmanuel, Inchauspe, Aurore, Mangeot, Philippe Emmanuel, Delberghe, Elodie, Chapus, Fleur, Neveu, Gregory, Alam, Antoine, Carter, Kara, Testoni, Barbara, Zoulim, Fabien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040760/ https://www.ncbi.nlm.nih.gov/pubmed/35389262 http://dx.doi.org/10.1128/mbio.02888-21 |
Ejemplares similares
-
Quantification and epigenetic evaluation of the residual pool of hepatitis B covalently closed circular DNA in long-term nucleoside analogue-treated patients
por: Lebossé, Fanny, et al.
Publicado: (2020) -
Gene Editing Technologies to Target HBV cccDNA
por: Martinez, Maria Guadalupe, et al.
Publicado: (2022) -
An Episomal CRISPR/Cas12a System for Mediating Efficient Gene Editing
por: Duan, Nannan, et al.
Publicado: (2021) -
CREEPY: CRISPR-mediated editing of synthetic episomes in yeast
por: Zhao, Yu, et al.
Publicado: (2023) -
An episomal CRISPR/Cas9 system to derive vector-free gene modified mammalian cells
por: Li, Linlin, et al.
Publicado: (2016)